日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Latanoprostene Bunod 0.024% in Patients with Open-Angle Glaucoma Switched from Prior Pharmacotherapy: A Retrospective Chart Review

拉坦前列素布诺德0.024%用于既往接受过药物治疗的开角型青光眼患者:一项回顾性病例分析

Okeke, Constance O; Cothran, Nora Lee; Brinkley, Desirae A; Rahmatnejad, Kamran; Rodiño, Frank J; Deom, James E

Retrospective Chart Review on Real-World Use of Latanoprostene Bunod 0.024% in Treatment-Naïve Patients with Open-Angle Glaucoma

回顾性图表分析拉坦前列素布诺德0.024%在初治开角型青光眼患者中的真实世界应用

Okeke, Constance O; Burstein, Eitan S; Trubnik, Valerie; Deom, James E; Cooper, Michael S; Brinkley, Desirae A; Thimons, J James; Kabiri, Alexander J; Gelb, Kerry M

Adenosine A1 receptor antagonist, L-97-1, improves survival and protects the kidney in a rat model of cecal ligation and puncture induced sepsis

腺苷 A1 受体拮抗剂 L-97-1 可提高盲肠结扎和穿刺诱发脓毒症大鼠模型的生存率并保护肾脏

Constance N Wilson, Constance O Vance, Melissa G Lechner, George M Matuschak, Andrew J Lechner